Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ORINCON was a technology company specializing in signal processing, pattern recognition, and neural networks, primarily serving the defense and intelligence communities. However, the company established a significant presence in the healthcare and life sciences sectors through its medical products group and its subsidiary, ORINCON Sygenex. The company developed advanced algorithms for medical signal analysis, including heart sound analysis for cardiac diagnosis and EEG/EKG processing, as well as bioinformatics software for genomic data analysis and drug discovery. ORINCON was acquired by Lockheed Martin in 2003 to integrate its sophisticated information technology and signal processing capabilities into Lockheed's broader systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orincon.